Basic science breaks through: New therapeutic advances in Parkinson's disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Basic science breaks through: New therapeutic advances in Parkinson's disease
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 30, Issue 11, Pages 1521-1527
Publisher
Wiley
Online
2015-07-16
DOI
10.1002/mds.26332
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intracellular Screening of a Peptide Library to Derive a Potent Peptide Inhibitor of α-Synuclein Aggregation
- (2015) Harish Cheruvara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Bacterial Curli System Possesses a Potent and Selective Inhibitor of Amyloid Formation
- (2015) Margery L. Evans et al. MOLECULAR CELL
- FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease
- (2015) Anke Van der Perren et al. NEUROBIOLOGY OF AGING
- Impaired intracellular trafficking defines early Parkinson's disease
- (2015) Benjamin H.M. Hunn et al. TRENDS IN NEUROSCIENCES
- Rising to the Challenges of Clinical Trial Improvement in Parkinson’s Disease
- (2015) Soania Mathur et al. Journal of Parkinsons Disease
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease
- (2015) Md Shahaduzzaman et al. PLoS One
- The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
- (2014) Johannes Levin et al. ACTA NEUROPATHOLOGICA
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials
- (2014) Markus Mandler et al. ACTA NEUROPATHOLOGICA
- Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
- (2014) Alisdair McNeill et al. BRAIN
- c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease
- (2014) Anne-Laure Mahul-Mellier et al. HUMAN MOLECULAR GENETICS
- Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson's disease
- (2014) Wenbin Xiao et al. IMMUNOBIOLOGY
- Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson’s disease and other Lewy body disorders
- (2014) Veronica Lindström et al. Immunotherapy
- Noninvasive Bioluminescence Imaging of α-Synuclein Oligomerization in Mouse Brain Using Split Firefly Luciferase Reporters
- (2014) Sarah-Ann Aelvoet et al. JOURNAL OF NEUROSCIENCE
- Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
- (2014) D. Games et al. JOURNAL OF NEUROSCIENCE
- Ten Years and Counting: Moving Leucine-Rich RepeatKinase 2 Inhibitors to the Clinic
- (2014) Andrew B. West MOVEMENT DISORDERS
- Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice
- (2014) Veronica Lindström et al. NEUROBIOLOGY OF DISEASE
- System-based approaches to decode the molecular links in Parkinson's disease and diabetes
- (2014) Jose A. Santiago et al. NEUROBIOLOGY OF DISEASE
- Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson Disease
- (2014) Maxwell B. Santana et al. NEURON
- Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease
- (2014) Paula L. McClean et al. NEUROPHARMACOLOGY
- Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats
- (2014) H.-Y. Cai et al. NEUROSCIENCE
- Calcineurin determines toxic versus beneficial responses to -synuclein
- (2014) G. Caraveo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic Spinal Cord Electrical Stimulation Protects Against 6-hydroxydopamine Lesions
- (2014) Amol P. Yadav et al. Scientific Reports
- Open questions for Alzheimer’s disease immunotherapy
- (2014) Todd E Golde Alzheimers Research & Therapy
- α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
- (2014) Hien T. Tran et al. Cell Reports
- Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
- (2014) Abid Oueslati et al. Experimental Neurobiology
- Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
- (2013) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- α-Synuclein: The Long Distance Runner
- (2013) Sonia George et al. BRAIN PATHOLOGY
- Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinson's disease models
- (2013) M. L. Hebron et al. HUMAN MOLECULAR GENETICS
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- A patient with Parkinson’s disease benefits from spinal cord stimulation
- (2013) Syed Hassan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation
- (2013) Therese Fagerqvist et al. JOURNAL OF NEUROCHEMISTRY
- Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress
- (2013) Mohit K. Sharma et al. JOURNAL OF NEUROCHEMISTRY
- α-Synuclein Vaccination Prevents the Accumulation of Parkinson Disease-Like Pathologic Inclusions in Striatum in Association With Regulatory T Cell Recruitment in a Rat Model
- (2013) Vanesa Sanchez-Guajardo et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
- (2013) B. B. Holmes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates -Synuclein Toxicity in Neurons
- (2013) D. F. Tardiff et al. SCIENCE
- Disease to Dirt: The Biology of Microbial Amyloids
- (2013) David A. Hufnagel et al. PLoS Pathogens
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- Beta oscillations in the cortico-basal ganglia loop during parkinsonism
- (2012) Edward Stein et al. EXPERIMENTAL NEUROLOGY
- Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats
- (2012) Wei-Na Han et al. NEUROBIOLOGY OF AGING
- Spinal Cord Stimulation for the Treatment of Abnormal Posture and Gait Disorder in Patients With Parkinson's Disease
- (2012) Takashi AGARI et al. NEUROLOGIA MEDICO-CHIRURGICA
- Spinal Cord Stimulation for the Treatment of Sensory Symptoms in Advanced Parkinson's Disease
- (2012) Andrea Landi et al. NEUROMODULATION
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease
- (2011) S. Z. Imam et al. JOURNAL OF NEUROSCIENCE
- Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson’s disease
- (2011) Gilles Fénelon et al. PARKINSONISM & RELATED DISORDERS
- Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
- (2010) H. S. Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Physiological functions of the HECT family of ubiquitin ligases
- (2009) Daniela Rotin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now